Skip to content

The effect of platelet-rich plasma and corticosteroids in the treatment of plantar fasciitis

Comparison The effect of platelet-riched plasma versus corticosteroids injection on the treatment of plantar fasciitis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220406054429N1
Enrollment
30
Registered
2022-06-12
Start date
2022-05-22
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis. Plantar fascial fibromatosis

Interventions

Intervention 1: First Intervention group: Corticosteroid injection, methylprednisolone 40 mg in a volume of 1 cc with 1 cc of 2% lidocaine, injected one time at the site of maximum tenderness. Interv

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years Existence of symptoms for more than 3 months Plantar fascia thickness above 4 mm on ultrasound examination VAS score equal to 6 and above

Exclusion criteria

Exclusion criteria: History of rheumatic diseases Diabetes or any malignancy Pregnancy Bleeding disorders Sores or infections at the injection site History of injections during the last 3 months Taking NSAIDS in the last week Suspicion of other diagnoses such as fractures or nerve disorders in the area

Design outcomes

Primary

MeasureTime frame
Plantar fascia thickness. Timepoint: At the beginning of the study and 3 months after the intervention. Method of measurement: Ultrasound device.;Pain. Timepoint: At the beginning of the study and 1 and 3 months after the intervention. Method of measurement: Visual analogue scale questionnaire.;Foot function. Timepoint: At the beginning of the study and 1 and 3 months after the intervention. Method of measurement: Foot and Ankle disability index and Roles and Maudsley score questionnaires.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Birjandi

Shahid Beheshti University of Medical Sciences

birjandi.ali68@gmail.com+98 21 2237 9790

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026